Trial NCT03187756

View at ClinicalTrials.gov 
Org. Study IDs: 17-00042

Last trial update was posted on 2020-03-27

MeSH Interventions

Cyclophosphamide

MeSH Conditions

Hematologic Neoplasms Neoplasms

Other Conditions

Hematopoietic Malignancies

Stopping Reasons

Procedure has become standard of care - protocol is no longer necessary

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID